GlassScriptPhysician profile
Lee R Sayner
NPI 1265422141
$3,446.45
in general payments reported to CMS, 2019-2025
20 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $143 · 2021: $457 · 2022: $591 · 2023: $785 · 2024: $545 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618 · Debt Forgiveness: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.18 |
| Debt Forgiveness | $243.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $534.54 | 2019-2025 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $457.71 | 2021-2025 | Nuzyra |
| Horizon Therapeutics Plc | $285.31 | 2019-2023 | Krystexxa |
| Djo, LLC | $243.49 | 2023 | |
| Amgen INC. | $238.12 | 2024-2025 | Krystexxa |
| Abbvie INC. | $217.10 | 2021-2022 | |
| Nevro Corp. | $206.97 | 2022-2024 | Senza |
| Melinta Therapeutics, LLC | $197.83 | 2019-2021 | |
| Stryker Corporation | $177.22 | 2022-2024 | Ortholoc 3di, Ortholoc 2 Lapifuse, Easyfuse |
| Medtronic Vascular, INC. | $142.54 | 2019-2020 | |
| Kerecis Limited | $140.76 | 2022 | |
| Mimedx Group, INC. | $132.75 | 2025 | |
| Orthofix Medical, INC. | $132.00 | 2023-2024 | Physio-Stim, Spinal-Stim |
| Amniox Medical, INC. | $124.94 | 2020 | |
| Boston Scientific Corporation | $60.16 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $56.67 | 2023 | |
| Rock Medical Orthopedics, INC. | $45.96 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $20.62 | 2025 | |
| Organogenesis INC. | $16.62 | 2023 | Puraply |
| Treace Medical Concepts, INC. | $15.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Sayner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.